tert-butyl 2,2-dimethyl-4-oxo-1-piperidinecarboxylate, 95.0%, 100mg

5-Bromo-4-ethoxy-2-((4-methoxybenzyl)oxy)pyridine, 97%, 1g

3-[(TERT-BUTOXY)CARBONYL]BICYCLO[1.1.1]PENTANE-1-CARBOXYLIC ACID, 95.0%, 10g

4-Bromo-3-methyl-1H-indole, 95.0%, 5g

N-alpha-Boc-N-gamma-Fmoc-L-Diaminobutyric acid, 98.0%, 5g

1,12-Dibromododecane>98.0%(GC)100g

[2-chloro-5-(trifluoromethyl)phenyl]hydrazine hydrochloride, 97%, 25g

1-(4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol, 95.0%, 1g

N,N,N-Trimethylbenzenaminium bromide, 95.0%, 100g

Hydroxyde de potassium, min 85%, Ph.Eur., en pastilles, 500 g, emballage plastique.

5-(4-Fluorophenyl)isoxazole-3-methanol, 98.5%, 100mg

(3,5-Dichloro-4-fluorophenyl)boronic acid, 97%, 5g

2-methylimidazo[1,2-a]pyridine-8-carboxylic acid dihydrochloride hydrate, 95.0%, 1g